Annabelle, who has relapsing MS, has become the first person to join a new clinical trial. The trial is testing whether two drugs together could help repair myelin, the protective covering around nerves. Researchers believe repairing myelin could help slow or stop MS progression.
Traditionally, clinical trials for MS have not included people who depend on a wheelchair to get around. But this is changing. Now you can find out more about the first clinical trial specifically for people with advanced MS at a special webinar!
We know people with MS taking certain disease modifying therapies (DMTs) may be less likely to develop an immune response to the COVID-19 vaccine. But we don’t know how much this affects your protection from getting COVID-19 or severe symptoms. A study published last week has taken us closer to some of these answers.
Researchers have shown new MRI techniques can detect previously unseen changes in the brains of people with early MS. Identifying these changes at an early stage may lead to more accurate predictions about how your MS will develop.
A new study by Dr Ruth Dobson and colleagues at Queen Mary University London found that people with MS had higher levels of vitamin D than people without MS, because they were more likely to take a supplement.
99 results found
Join the Research Network
Our Research Network make sure all the research we fund reflects the needs and interests of people living with MS. And they help us talk about it in a way that’s accessible to everyone.
Anyone who lives with MS or cares for someone who does can get involved. It doesn't matter where in the UK you live or how much research experience you have.